Robert Barrow
Chief Executive Officer bij MIND MEDICINE (MINDMED) INC.
Vermogen: 5 M $ op 31-03-2024
Profiel
Robert Barrow is currently the Chief Executive Officer & Director at Mind Medicine (MindMed), Inc. since 2021.
He is also the Owner of Jasper Biopharmaceutical Advisors LLC since 2018.
Previously, he served as the Director-Drug Development at Promega Corp.
from 2019 to 2020 and as the Director-Drug Development & Discovery at Usona Institute from 2019 to 2020.
He was also the Chief Operating Officer at Olatec Therapeutics LLC and the Chief Financial Officer at Olatec Therapeutics LLC from 2009 to 2018.
Mr. Barrow received his undergraduate degree from Wake Forest University and his graduate degree from The Ohio State University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
25-03-2024 | 580 202 ( 0.82% ) | 5 M $ | 31-03-2024 |
Actieve functies van Robert Barrow
Bedrijven | Functie | Begin |
---|---|---|
MIND MEDICINE (MINDMED) INC. | Chief Executive Officer | 09-06-2021 |
Jasper Biopharmaceutical Advisors LLC | Corporate Officer/Principal | 01-01-2018 |
Eerdere bekende functies van Robert Barrow
Bedrijven | Functie | Einde |
---|---|---|
Usona Institute
Usona Institute Miscellaneous Commercial ServicesCommercial Services Usona Institute is a private company that focuses on exploring and learning about consciousness-expanding medicines to address mental health conditions. The company is based in Madison, WI. The company's mission is to contribute new pathways into awakening and connection for those in need. The company was founded in 2014 by William Alderman Linton. | Corporate Officer/Principal | 01-07-2020 |
Promega Corp.
Promega Corp. BiotechnologyHealth Technology Promega Corp. manufactures enzyme systems. Its products include cell biology, nucleic acid analysis, drug development, molecular diagnostics, and lab equipment and supplies. The company was founded by William Alderman Linton in 1978 and is headquartered in Madison, WI. | Corporate Officer/Principal | 01-01-2020 |
Olatec Therapeutics LLC
Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation. | Director of Finance/CFO | 01-01-2018 |
Olatec Therapeutics LLC
Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation. | Chief Operating Officer | - |
Opleiding van Robert Barrow
Wake Forest University | Undergraduate Degree |
The Ohio State University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MIND MEDICINE (MINDMED) INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Promega Corp.
Promega Corp. BiotechnologyHealth Technology Promega Corp. manufactures enzyme systems. Its products include cell biology, nucleic acid analysis, drug development, molecular diagnostics, and lab equipment and supplies. The company was founded by William Alderman Linton in 1978 and is headquartered in Madison, WI. | Health Technology |
Usona Institute
Usona Institute Miscellaneous Commercial ServicesCommercial Services Usona Institute is a private company that focuses on exploring and learning about consciousness-expanding medicines to address mental health conditions. The company is based in Madison, WI. The company's mission is to contribute new pathways into awakening and connection for those in need. The company was founded in 2014 by William Alderman Linton. | Commercial Services |
Olatec Therapeutics LLC
Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation. | Health Technology |
Jasper Biopharmaceutical Advisors LLC |